Liraglutide
Also known as Victoza, Saxenda
Liraglutide is a once-daily GLP-1 injection for type 2 diabetes (Victoza) and weight loss (Saxenda) — it curbs appetite and slows how fast your stomach empties.
One-dose burn-down
Half-life
13 h
Tmax
10 h
Bioavailability
55%
Steady state
~3d
Typical dose
0.6 mg
Once-daily GLP-1 receptor agonist for type 2 diabetes (Victoza) and weight management (Saxenda).
Mechanism of action
Fatty-acid-acylated GLP-1 analog with albumin binding extending half-life to ~13 h, enabling once-daily dosing.
Boxed warning for thyroid C-cell tumors. Daily injection.
Track Liraglutide for free
Log your doses and PeptideBuddy models Liraglutide's half-life into a live chart so you always know how much is active — plus reminders, reconstitution and protocol planning.
Start tracking free